The role of tau in Alzheimer's disease

Medical Clinics of North America

Volumn 86, Issue 3, 2002, Pages 615-627

  Trojanowski, John Q ^a   Lee, Virginia M Y ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TAU PROTEIN;

ALZHEIMER DISEASE; BRAIN DEGENERATION; CELL FUNCTION; DISEASE ACTIVITY; DISEASE COURSE; GENE MUTATION; GENETIC POLYMORPHISM; HEREDITY; HUMAN; MICROTUBULE; NERVE DEGENERATION; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW;

ALZHEIMER DISEASE; BRAIN; HUMANS; TAU PROTEINS; TAUOPATHIES;

EID: 0036323020     PISSN: 00257125     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0025-7125(02)00002-0     Document Type: Review

References (113)

1. Tau protein isoforms, phosphorylation and role in neurodegenerative disorders
2. New insights into genetic and molecular mechanisms of brain degeneration in tauopathies
3. Neurodegenerative tauopathies
4. Pathogenic implications of mutations in the tau gene in pallido-ponto-nigral degeneration and related neurodegenerative disorders linked to chromosome 17
5. Segregation of a missense mutation in the microtubule-associated protein tau gene with familial frontotemporal dementia and parkinsonism
6. Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17
7. Tau is a candidate gene for chromosome 17 frontotemporal dementia
8. Mutation in the tau gene in familial multiple system tauopathy with presenile dementia
9. The distribution of tau in the mammalian central nervous system
10. Physical and chemical properties of purified tau factor and the role of tau in microtubule assembly
11. Purification of tau, a microtubule-associated protein that induces assembly of microtubules from purified tubulin
12. Primary structure of high molecular weight tau present in the peripheral nervous system
13. Functional implications for the microtubule-associated protein tau: Localization in oligodendrocytes
14. The distribution of tau in the normal human nervous system
15. Structure and novel exons of the human tau gene
16. Cloning and sequencing of the cDNA encoding a core protein of the paired helical filament of Alzheimer disease: Identification as the microtubule-associated protein tau
17. Identification of cDNA clones for the human microtubule-associated protein tau and chromosomal localization of the genes for tau and microtubule-associated protein 2
18. Multiple isoforms of human microtubule-associated protein tau: Sequences and localization in neurofibrillary tangles of Alzheimer's disease
19. Cloning and sequencing of the cDNA encoding an isoform of microtubule-associated protein tau containing four tandem repeats: Differential expression of tau protein mRNAs in human brain
20. Expression of separate isoforms of human tau protein: Correlation with the tau pattern in brain and effects on tubulin polymerization
21. Mutation-specific functional impairments in distinct tau isoforms of hereditary FTDP-17
22. High molecular weight tau: Preferential localization in the peripheral nervous system
23. Cloning of a big tau microtubule-associated protein characteristic of the peripheral nervous system
24. Tau protein binds to microtubules through a flexible array of distributed weak sites
25. Tau consists of a set of proteins with repeated C-terminal microtubule-binding domains and variable N-terminal domains
26. The microtubule binding domain of tau protein
27. A protein factor essential for microtubule assembly
28. Functional interactions between the proline-rich and repeat regions of tau enhance microtubule binding and assembly
29. Identification of a novel microtubule binding and assembly domain in the developmentally regulated inter-repeat region of tau
30. Domains of tau protein and interactions with microtubules
31. Abnormal tau phosphorylation at Ser396 in Alzheimer's disease recapitulates development and contributes to reduced microtubule binding
32. The abnormal phosphorylation of tau protein at Ser-202 in Alzheimer disease recapitulates phosphorylation during development
33. Fetal-type phosphorylation of the tau in paired helical filaments
34. The phosphorylation state of tau in the developing rat brain is regulated by phosphoprotein phosphatases
35. In vivo phosphorylation sites in fetal and adult rat tau
36. Modulation of the dynamic instability of tubulin assembly by the microtubule-associated protein tau
37. Tau in paired helical filaments is functionally distinct from fetal tau: Assembly incompetence of paired helical filament-tau
38. Phosphorylation of Ser262 strongly reduces binding of tau to microtubules: Distinction between PHF-like immunoreactivity and microtubule binding
39. Detection of phosphorylated Ser262 in fetal tau, adult tau, and paired helical filament tau
40. Mitogen activated protein (MAP) kinase transforms tau protein into an Alzheimer-like state
41. p42 MAP kinase phosphorylation sites in microtubule-associated protein tau are dephosphorylated by protein phosphatase 2A1. Implications for Alzheimer's disease
42. Glycogen synthase kinase-3 induces Alzheimer's disease-like phosphorylation of tau: Generation of paired helical filament epitopes and neuronal localisation of the kinase
43. Lithium reduces tau phosphorylation by inhibition of glycogen synthase kinase-3
44. Insulin and insulin-like growth factor-1 regulate tau phosphorylation in cultured human neurons
45. Glycogen synthase kinase-3 and the Alzheimer-like state of microtubule-associated protein tau
46. Abnormal Alzheimer-like phosphorylation of tau-protein by cyclin-dependent kinases cdk2 and cdk5
47. A cdc2-related kinase PSSALRE/cdk5 is homologous with the 30 kDa subunit of tau protein kinase II, a proline-directed protein kinase associated with microtubule
48. Phosphorylation by cAMP-dependent protein kinase inhibits the degradation of tau by calpain
49. Phosphorylation of tau proteins to a state like that in Alzheimer's brain is catalyzed by a calcium/calmodulin-dependent kinase and modulated by phospholipids
50. MARK, a novel family of protein kinases that phosphorylate microtubule-associated proteins and trigger microtubule disruption
51. Phosphorylation of microtubule-associated protein tau by stress-activated protein kinases
52. Reactivating kinase/p38 phosphorylates tau protein in vitro
53. Stress-activated protein kinase/c-jun N-terminal kinase phosphorylates tau protein
54. Identification of the 23 kDa subunit of tau protein kinase II as a putative activator of cdk5 in bovine brain
55. Phosphorylation of tau by glycogen synthase kinase-3 beta in intact mammalian cells: The effects on the organization and stability of microtubules
56. Modulation of GSK-3-catalyzed phosphorylation of microtubule-associated protein tau by non-proline-dependent protein kinases
57. Involvement of tau protein kinase I in paired helical filament-like phosphorylation of the juvenile tau in rat brain
58. Paullones are potent inhibitors of glycogen synthase kinase-3beta and cyclin-dependent kinase 5/p25
59. Lithium reduces tau phosphorylation: Effects in living cells and in neurons at therapeutic concentrations
60. Lithium inhibits Alzheimer's disease-like tau protein phosphorylation in neurons
61. Lithium inhibits neurite growth and tau protein kinase I/glycogen synthase kinase-3beta-dependent phosphorylation of juvenile tau in cultured hippocampal neurons
62. A brain-specific activator of cyclin-dependent kinase 5
63. p35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5
64. Potentiation of GSK-3-catalyzed Alzheimer-like phosphorylation of human tau by cdk5
65. Interaction of neuronal cdc2 like protein kinase with microtubule associated protein tau
66. Preferential labeling of Alzheimer neurofibrillary tangles with antisera for tau protein kinase (TPK) I/glycogen synthase kinase-3 beta and cyclin-dependent kinase 5, a component of TPK II
67. Dephosphorylation of tau protein and Alzheimer paired helical filaments by calcineurin and phosphatase-2A
68. Protein phosphatase 2A is the major enzyme in brain that dephosphorylates tau protein phosphorylated by proline-directed protein kinases or cyclic AMP-dependent protein kinase
69. Biopsy-derived adult human brain tau is phosphorylated at many of the same sites as Alzheimer's disease paired helical filament tau
70. Protein phosphatase 1 is targeted to microtubules by the microtubule-associated protein tau
71. A novel pool of protein phosphatase 2A is associated with microtubules and is regulated during the cell cycle
72. Molecular interactions among protein phosphatase 2A, tau, and microtubules. Implications for the regulation of tau phosphorylation and the development of tauopathies
73. Selective destruction of stable microtubules and axons by inhibitors of protein serine/threonine phosphatases in cultured human neurons
74. Mise en evidence immunologique de la proteine tau au niveau des lesions de degenerescence neurofibrillaire de la maladie d'Alzheimer
75. Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology
76. Paired helical filaments in electron microscopy of Alzheimer's disease
77. Straight and paired helical filaments in Alzheimer disease have a common structural unit
78. A preparation of Alzheimer paired helical filaments that displays distinct tau proteins by polyacrylamide gel electrophoresis
79. Hydrofluoric acid-treated tau PHF proteins display the same biochemical properties as normal tau
80. The carboxyl third of tau is tightly bound to paired helical filaments
81. Epitopes that span the tau molecule are shared with paired helical filaments
82. A68: A major subunit of paired helical filaments and derivatized forms of normal tau
83. Isolation of a fragment of tau derived from the core of the paired helical filament of Alzheimer disease
84. Molecular dissection of the paired helical filament
85. Hyperphosphorylation of tau in PHF
86. Characterization of mAb AP422, a novel phosphorylation-dependent monoclonal antibody against tau protein
87. Unique Alzheimer's disease paired helical filament specific epitopes involve double phosphorylation at specific sites
88. Sequential phosphorylation of Tau by glycogen synthase kinase-3beta and protein kinase A at Thr212 and Ser214 generates the Alzheimer-specific epitope of antibody AT100 and requires a paired-helical-filament-like conformation
89. Calpain-dependent proteolytic cleavage of the p35 cyclin-dependent kinase 5 activator to p25
90. Neurotoxicity induces cleavage of p35 to p25 by calpain
91. Processing of cdk5 activator p35 to its truncated form (p25) by calpain in acutely injured neuronal cells
92. Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration
93. The prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau protein
94. Phosphorylation that detaches tau protein from microtubules (Ser262, Ser214) also protects it against aggregation into Alzheimer paired helical filaments
95. Structural studies of tau protein and Alzheimer paired helical filaments show no evidence for beta-structure
96. Natural methylamine osmolytes, trimethylamine N-oxide and betaine, increase tau-induced polymerization of microtubules
97. Phosphorylated tau can promote tubulin assembly
98. A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads
99. The microtubule binding repeats of tau protein assemble into filaments like those found in Alzheimer's disease
100. Tau proteins of Alzheimer paired helical filaments: Abnormal phosphorylation of all six brain isoforms
101. Alzheimer-like paired helical filaments and antiparallel dimers formed from microtubule-associated protein tau in vitro
102. Role of glycosaminoglycans in determining the helicity of paired helical filaments
103. Assembly of microtubule-associated protein tau into Alzheimer-like filaments induced by sulphated glycosaminoglycans
104. Polymerization of tau into filaments in the presence of heparin: The minimal sequence required for tau-tau interaction
105. Assembly of tau protein into Alzheimer paired helical filaments depends on a local sequence motif ((306)VQIVYK(311)) forming beta structure
106. A nucleated assembly mechanism of Alzheimer paired helical filaments
107. Alzheimer-like changes in microtubule-associated protein Tau induced by sulfated glycosaminoglycans. Inhibition of microtubule binding, stimulation of phosphorylation, and filament assembly depend on the degree of sulfation
108. RNA stimulates aggregation of microtubule-associated protein tau into Alzheimer-like paired helical filaments
109. Free fatty acids stimulate the polymerization of tau and amyloid beta peptides. In vitro evidence for a common effector of pathogenesis in Alzheimer's disease
110. RNA sequestration to pathological lesions of neurodegenerative diseases
111. Early accumulation of heparan sulfate in neurons and in the beta- amyloid protein-containing lesions of Alzheimer's disease and Down's syndrome
112. Agrin is a major heparan sulfate proteoglycan accumulating in Alzheimer's disease brain
113. In vitro polymerization of tau protein monitored by laser light scattering: Method and application to the study of FTDP-17 mutants